Comparing Weight-Management Treatment Pathways in Australia — Patient Information
General patient information about comparing weight-management treatment pathways in Australia: TGA-approved indications, AHPRA-prescriber requirements, PBS context and the questions to discuss before treatment. Not an advertisement and not medical advice.
Important information for Australian consumers
Several prescription-only (Schedule 4) medicines are TGA-approved for weight management in Australia. Australian regulations restrict the advertising of prescription medicines to consumers, so this page does not list specific medicine prices or compare medicines on price. The choice of treatment pathway is a clinical decision for an AHPRA-registered prescriber following an assessment. Always read the label and follow the directions for use.
About choosing a weight-management pathway
Several prescription-only medicines are TGA-approved for weight management in Australia, with different active ingredients, dosing schedules and side-effect profiles. Australian regulations restrict advertising of prescription medicines to consumers, so this page does not list specific medicine prices or recommend any particular product. The choice between treatment pathways is a clinical decision for an AHPRA-registered prescriber following an assessment.
What to discuss with an AHPRA-registered prescriber
- Which TGA-approved treatment options are appropriate for your clinical circumstances.
- The dosing schedule, expected treatment duration and follow-up requirements for each option.
- Side effects, contraindications and interactions with other medicines.
- PBS eligibility for any subsidised indication you may qualify for.
- Non-medicine pathways, including dietary and behavioural support, and where they fit alongside any prescribed treatment.
How service-level fees compare across consultation routes
The cost of the consultation, not the medicine, is what differs most between consultation routes. Any medicine supply is handled after a valid prescription through a dispensing pharmacy. Useful service-level comparisons:
- GP consultation route — consultation fee plus any Medicare rebate where an item number applies. Familiar GP relationship; you choose the dispensing pharmacy.
- Telehealth programme route — programme fee, sometimes bundling consultation, follow-up review and dispensing into a single monthly figure. Confirm what is included in the fee.
- Specialist obesity / metabolic clinic — broader assessment, often higher consultation fee, may be appropriate for more complex clinical situations.
Compare consultation routes on their service fees and what is bundled into them — not on the medicine they may prescribe.
Questions to take into a consultation
- Which treatment options are TGA-approved for my clinical circumstances?
- What is the dose-escalation schedule and expected treatment duration?
- What monitoring is needed during and after treatment?
- What are the side effects, contraindications and interactions with my other medicines?
- What happens if I need to stop the treatment?
- What does each part of the cost cover — consultation, prescription, dispensing, follow-up review, delivery?
Australia hub
Related Australian healthcare information
Sources and updates
How this page is sourced
Sources
- TGA medicine information
- PBS schedule (pbs.gov.au)
- AHPRA Register of Practitioners
Methodology: This page is general patient information about comparing weight-management treatment pathways. Brand-name cost tables, medicine-vs-medicine price comparisons and Offer/AggregateOffer schema are not displayed for compliance with the TGA Therapeutic Goods Advertising Code.
Caveat: This page is not medical advice and is not a recommendation to use any prescription medicine. Speak with an AHPRA-registered prescriber.
FAQs
How do I choose between weight-management treatment pathways in Australia?
The choice is a clinical decision for an AHPRA-registered prescriber following an assessment of your circumstances, history and goals. Discuss the TGA-approved indication, dose schedule, side-effect profile and PBS eligibility for each option you are considering.
Are any weight-management medicines PBS-subsidised in Australia?
GLP-1 weight-management medicines are not currently PBS-subsidised for obesity in Australia. PBS subsidy for semaglutide (Ozempic) applies only to eligible patients with type 2 diabetes. Check the current PBS schedule at pbs.gov.au.
What costs are involved in a private weight-management consultation?
Costs depend on the provider and may include consultation fees, follow-up review fees, dispensing fees and delivery. Ask the provider for a written service-fee breakdown before paying.
Can I use telehealth for weight-management treatment in Australia?
Telehealth weight-management consultations are available with AHPRA-registered prescribers. Verify the practitioner on the AHPRA Register of Practitioners and confirm what is included in any programme fee.
What questions should I take to a weight-management consultation?
Ask about the TGA-approved indication, dose schedule, expected duration of treatment, monitoring requirements, side effects, what happens if you stop, alternatives, and the full cost structure including consultation, dispensing and follow-up.